28 Mar 2024

Boundless Bio raises $100m as IPO market rouses

US-based Boundless Bio will offer 6,250,000 shares for $16 each as the oncology company hears the bell on the Nasdaq market for the first time today (28 March).    According…

28 Mar 2024

Blackstone to provide $750m for Moderna’s ‘flu programme

Blackstone Life Sciences has entered a development and commercialisation funding agreement with Moderna, committing $750m to support the latter’s influenza programme. The collaboration is part of Blackstone's strategy to support…

[ajax_load_more post_type="post" taxonomy="category" taxonomy_terms="company-news, contract-news, deal-news, industry-news, news" taxonomy_operator="IN" images_loaded="true" posts_per_page="20" offset="7" pause="true" scroll="false" button_label="Load More Stories"]